219 studies found for:    "thrombotic thrombocytopenic purpura" OR "Purpura, Thrombocytopenic"
Show Display Options
Rank Status Study
21 Recruiting Early Predictive Factors of Cardiac and Cerebral Involvement in TMA
Conditions: Thrombotic Microangiopathy,;   Thrombotic Thrombocytopenic Purpura,
Intervention: Other: Biological and imaging investigations
22 Completed
Has Results
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenic Purpura
Interventions: Other: Retrospective Chart Review;   Other: Patient-reported Outcome Questionnaires;   Other: Physician Survey
23 Completed
Has Results
Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenic Purpura
Interventions: Drug: Medical Standard of Care for ITP;   Biological: Romiplostim
24 Completed
Has Results
Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Idiopathic Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Eltrombopag oral tablets
25 Completed
Has Results
Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)
Condition: Purpura, Thrombocytopaenic, Idiopathic
Intervention: Drug: eltrombopag
26 Completed Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Rituximab;   Drug: Placebo
27 Recruiting A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Eltrombopag Tablets;   Drug: Eltrombopag PfOS
28 Completed
Has Results
Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Fostamatinib Disodium / R935788
29 Completed
Has Results
A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopaenic, Idiopathic
Intervention: Drug: Eltrombopag olamine
30 Active, not recruiting Study of Veltuzumab (hA20) at Different Doses in Patients With ITP
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Autoimmune Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Autoimmune
Intervention: Biological: veltuzumab
31 Recruiting A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Hetrombopag Olamine
32 Completed Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: BI 655064
33 Terminated Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy
Conditions: Thrombotic Microangiopathy;   Thrombotic Thrombocytopenic Purpura
Interventions: Drug: ARC 1779 Placebo;   Drug: ARC1779 Injection
34 Completed Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura
Conditions: Idiopathic Thrombocytopenic Purpura;   Immune Thrombocytopenic Purpura
Intervention: Biological: Inactivated Trivalent Influenza vaccine
35 Completed Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Idiopathic Thrombocytopenic Purpura (ITP);   Immune Thrombocytopenic Purpura (ITP)
Intervention: Drug: rituximab
36 Completed Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients
Conditions: Immune Thrombocytopenic Purpura;   Helicobacter Pylori Infection
Intervention: Drug: H. pylori triple therapy
37 Completed Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)
Condition: Thrombocytopenic Purpura
Intervention: Drug: AMG 531
38 Completed
Has Results
Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Interventions: Drug: Placebo;   Drug: AMG 531
39 Completed Efficacy and Safety of IVIG-L in ITP Patients
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: IVIG-L
40 Completed
Has Results
Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)
Conditions: Thrombocytopenia;   Idiopathic Thrombocytopenic Purpura
Intervention: Biological: romiplostim

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years